These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34177421)

  • 21. Systematic review and meta-analysis of the clinical effectiveness of point-of-care testing for anticoagulation management during ECMO.
    Jiritano F; Fina D; Lorusso R; Ten Cate H; Kowalewski M; Matteucci M; Serra R; Mastroroberto P; Serraino GF
    J Clin Anesth; 2021 Oct; 73():110330. PubMed ID: 33962338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing Coagulation by Rotational Thromboelastometry (ROTEM) in Rivaroxaban-Anticoagulated Blood Using Hemostatic Agents.
    Bar J; David A; Khader T; Mulcare M; Tedeschi C
    Prehosp Disaster Med; 2017 Oct; 32(5):580-587. PubMed ID: 28625215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding-A Systematic Review and a Cohort Study.
    Hvas CL; Larsen JB; Adelborg K; Christensen S; Hvas AM
    Semin Thromb Hemost; 2022 Feb; 48(1):31-54. PubMed ID: 34715692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Anticoagulation in COVID-19-Induced Hypercoagulability.
    Rico-Mesa JS; Rosas D; Ahmadian-Tehrani A; White A; Anderson AS; Chilton R
    Curr Cardiol Rep; 2020 Jun; 22(7):53. PubMed ID: 32556892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability.
    van de Berg TW; Hulshof AM; Nagy M; van Oerle R; Sels JW; van Bussel B; Ten Cate H; Henskens Y; Spronk HMH;
    Thromb Res; 2021 May; 201():84-89. PubMed ID: 33662799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
    Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
    Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case Series of Thromboelastography-Guided Anticoagulation in COVID-19 Patients with Inherited and Acquired Hypercoagulable States.
    Thomas AV; Lin KP; Stillson JE; Bunch CM; Speybroeck J; Wiarda G; Al-Fadhl H; Gillespie L; Zamlut M; Fulkerson DH; Khan RZ; Kwaan HC; Walsh MM
    Case Rep Med; 2021; 2021():5568982. PubMed ID: 34367290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    J Thromb Thrombolysis; 2020 Aug; 50(2):281-286. PubMed ID: 32394236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viscoelastic hemostasis assays in septic, critically ill coronavirus disease 2019 patients: a practical guide for clinicians.
    Gergi M; Goodwin A; Freeman K; Colovos C; Volod O
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):225-228. PubMed ID: 33443923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation for hypercoagulability in severe critical COVID-19: A case series of fading and fatal cycles of microthrombosis.
    Ronderos Botero DM; Omar AMS; Nicu M; Sklyar E; Bella JN; Chilimuri S
    J Cardiol Cases; 2021 Nov; 24(5):218-222. PubMed ID: 34567288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19.
    Schrick D; Tőkés-Füzesi M; Réger B; Molnár T
    Metabolites; 2021 Nov; 11(12):. PubMed ID: 34940584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy.
    Nagle EL; Tsu LV; Dager WE
    Ann Pharmacother; 2011 Sep; 45(9):e47. PubMed ID: 21862711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viscoelastic testing inside and beyond the operating room.
    Shen L; Tabaie S; Ivascu N
    J Thorac Dis; 2017 Apr; 9(Suppl 4):S299-S308. PubMed ID: 28540073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients.
    Boss K; Kribben A; Tyczynski B
    Thromb J; 2021 Feb; 19(1):10. PubMed ID: 33573670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment.
    Gąsecka A; Borovac JA; Guerreiro RA; Giustozzi M; Parker W; Caldeira D; Chiva-Blanch G
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):215-229. PubMed ID: 33074525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis.
    Aribawa IGNM; Hidayat L; Dewi PU; Ryalino C
    Am J Case Rep; 2021 May; 22():e930667. PubMed ID: 33967265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When does obstetric coagulopathy occur and how do I manage it?
    Collis RE; Kenyon C; Roberts TCD; McNamara H
    Int J Obstet Anesth; 2021 May; 46():102979. PubMed ID: 33906823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study.
    Herrmann J; Notz Q; Schlesinger T; Stumpner J; Kredel M; Sitter M; Schmid B; Kranke P; Schulze H; Meybohm P; Lotz C
    Thromb J; 2021 Jun; 19(1):39. PubMed ID: 34078393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.